期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

内皮细胞微粒与创伤脓毒症关系研究进展 被引量：1

原文传递
导出
摘要 脓毒症是烧（创）伤后一种严重的并发症，其病死率居高不下，可达30％～70％。脓毒症的发病机制非常复杂，但目前认为主要由过度炎性反应、微血管栓塞和内皮细胞功能失调这三方面因素造成。
作者 唐佳俊 郇京宁
机构地区 上海交通大学医学院附属瑞金医院烧伤整形科
出处 《中华烧伤杂志》 CAS CSCD 北大核心 2010年第1期26-29,共4页 Chinese Journal of Burns
关键词 内皮细胞功能失调 脓毒症 创伤 微粒 过度炎性反应 烧(创)伤 微血管栓塞 发病机制
分类号 R459.7 [医药卫生—急诊医学]
  • 相关文献

参考文献23

  • 1Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res, 2003,109 (4) : 175-180.
  • 2Perez-Casal M, Downey C, Fukudome K, et al. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood, 2005,105(4):1515-1522.
  • 3Miguet L, Paeaud K, Felden C, et al. Proteomic analysis of malignant lymphocyte membrane micropartieles using double ionization coverage optimization. Proteomics, 2006,6 ( 1 ) : 153-171.
  • 4Martinez MC, Tesse A, Zobairi F, et al. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol, 2005,288 (3): H 1004-1009.
  • 5Ogura H, Tanaka H, Koh T, et al. Enhanced production of endothelial microparticles with increased binding to leucocytes in patients with severe systemic inflammatory response syndrome. J Trauma, 2004,56(4) :823-831.
  • 6Mortaza S, Martinez MC, Baron-Menguy C, et al. Detrimental hemodynamie and inflammatory effects of microparticles originating from septic rats. Crit Care Med, 2009,37(6) :2045-2050.
  • 7Soriano AO, Jy W, Chirinos JA, et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med, 2005,33 ( 11 ) :2540-2546.
  • 8Peterson DB, Sander T, Kaul S, et al. Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics, 2008,8 (12) :2430-2446.
  • 9Mezentsev A, Merks RM, O'Riordan E, et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol, 2005,289 ( 3 ) : H1106-1114.
  • 10Yu JL, Rak JW. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost, 2004,2 ( 11 ) :2065-2067.

二级参考文献8

  • 1Ten Care H. Pathophysiology of disseminated intravaseular coagulation in sepsis[J]. Crit Care Med, 2000,28(9supple):S9 -S11.
  • 2Menges T, Hermans PW, Little SG, et al. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients[J]. Lancet, 2001,357: 1096 - 1097.
  • 3Yan SB, Heherbrand JD, Hartman DL, et al. Low levels of protein C are associated with poor outcomes in severe sepsis [ J ]. Chest, 2001,120:915 -922.
  • 4Warren BL, Eid A, Singer P, et al. Caring for the critically ill patirnts. High-dose antithrombin Ⅲ in severe sepsis: A randomized controlled trial[ J]. JAMA, 2001,286: 1869 - 1578.
  • 5Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis [ J ]. New Engl J Med, 2001,344(10) : 699 -709.
  • 6Barton P, Kalil AC, Nadel S, et al. Safety, pharmacokinetics and ppharmacodynamics of drotrecogin alfa ( activated ) in children with severe sepsis [ J ]. Pediatrics, 2004,113 ( 1 Pt 1 ) : 7 - 17.
  • 7Abraham E, Reinhart K, Svoboda P,et al. Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A muhicenter, randomized, placebo-controlled, single- blind, dose escalation study [ J ]. Crit Care Med, 2001,29 ( 11 ) : 2081 - 2089.
  • 8Abraham E, Reinhart K, Opal S, et al. Efficacy and safety of recombinant tifacogin ( tissue factor pathway inhibitor) in severe sepsis [ J ]. JAMA, 2003,290 ( 2 ): 238 - 247.

共引文献8

同被引文献3

引证文献1

二级引证文献2

中华烧伤杂志
2010年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部